Home/ Products / Biosimilar Antibodies
DMS1022-100ug
100 ug
$350
| target | CD19 |
| alias | CD19, 4, VID3, GC12802 |
| gene id | Uniprote ID: P15391 |
| host species | Humanized |
| reactivity | Human |
| iso type | IgG1 |
| formulation | Lyophilized from sterile PBS, pH 7.4. Typically, 5% - 8% trehalose is added as a protective agent prior to lyophilization. |
| reconstitution | Reconstitute lyophilized powder with water to a concentration of 100 ug/ml, solubilize at RT for 30 minutes with occasional gentle tapping. It is recommended that 0.1% HSA be added as a carrier protein for long-term storage. |
| applications | ELISA; Flow Cytometry |
| dilution | ELISA 1:5000-10000; Flow Cyt 1:100 |
| shipping | Shipped at ambient conditions. |
| storage | Lyophilized form is stable for 1 week at room temperature. Store at -20 °C to -80 °C for 12 months in lyophilized form. After reconstitution, store at 4 °C for 2-7 days or at below -20 °C for up to 3 months. |
| note | Other commonly used names in publications refering to this antibody: MEDI-551,Medi-551 |
Flow cytometry analysis of anti-CD19 mAb 1 ug/ml (inebilizumab) on Expi293 cells transfected with human CD19 (Blue histogram) or Expi293 transfected with irrelevant protein (Red histogram).
ELISA plate coated with 2 ug/mL (100 uL/well) Human CD19 Protein, mFc Tag binds to anti-CD19 (inebilizumab biosimilar) mAb in a linear range of 0.64?16 ng/mL.
DMS1022-100ug
100 ug
$350